{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:40Z","timestamp":1791928780069,"version":"4.3.4"},"reference-count":28,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2022,4,29]]},"DOI":"10.1167\/iovs.63.4.26","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T19:35:27Z","timestamp":1651260927000},"page":"26","source":"Crossref","is-referenced-by-count":6,"title":["Ocular Hypotensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (K\n                    <sub>ATP<\/sub>\n                    ) Channel Opening Prodrug"],"prefix":"10.1167","volume":"63","author":[{"given":"Cynthia L.","family":"Pervan-Steel","sequence":"first","affiliation":[{"name":"Qlaris Bio, Inc., Wellesley, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttio","family":"Roy Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemchand K.","family":"Sookdeo","sequence":"additional","affiliation":[{"name":"Qlaris Bio, Inc., Wellesley, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Casale","sequence":"additional","affiliation":[{"name":"Qlaris Bio, Inc., Wellesley, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Dosa","sequence":"additional","affiliation":[{"name":"Institute for Therapeutics Discovery and Development, Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurein M.","family":"Htoo","sequence":"additional","affiliation":[{"name":"Qlaris Bio, Inc., Wellesley, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Fautsch","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Wirostko","sequence":"additional","affiliation":[{"name":"Qlaris Bio, Inc., Wellesley, Massachusetts, United States"},{"name":"Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"bib7","article-title":"Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma","author":"Mehta","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.17925\/EOR.2011.05.02.116","article-title":"Adverse effects, adherence and cost-benefits in glaucoma treatment","volume":"5","author":"Denis","year":"2011","journal-title":"European Ophthalmic Review"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(86)90532-5","article-title":"Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985","volume":"102","author":"Nelson","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.ajoc.2020.100800","article-title":"Netarsudil-associated epithelial keratopathy","volume":"19","author":"Ramakrishnan","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)","volume":"200","author":"Kahook","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/physiol.1998.60.issue-1","article-title":"A view of sur\/KIR6.X, KATP channels","volume":"60","author":"Babenko","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.2501869","article-title":"Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle","volume":"245","author":"Standen","year":"1989","journal-title":"Science"},{"key":"bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/cphy.c170048","article-title":"ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles","volume":"8","author":"Tinker","year":"2018","journal-title":"Compr Physiol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exer.2016.04.020","article-title":"ATP sensitive potassium channel openers: A new class of ocular hypotensive agents","volume":"158","author":"Roy Chowdhury","year":"2017","journal-title":"Exp Eye Res"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"e0231841","DOI":"10.1371\/journal.pone.0231841","article-title":"Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits","volume":"15","author":"Roy Chowdhury","year":"2020","journal-title":"PLoS One"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1167\/iovs.17-22538","article-title":"Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents","volume":"58","author":"Roy Chowdhury","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"e0141783","DOI":"10.1371\/journal.pone.0141783","article-title":"Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems","volume":"10","author":"Roy Chowdhury","year":"2015","journal-title":"PLoS One"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1167\/iovs.13-11872","article-title":"ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure in vivo","volume":"54","author":"Chowdhury","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.63.2.15","article-title":"Effect of ATP-sensitive Potassium Channel Openers on Intraocular Pressure in Ocular Hypertensive Animal Models","volume":"63","author":"Roy Chowdhury","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1021\/acs.jmedchem.6b00406","article-title":"Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity","volume":"59","author":"Roy Chowdhury","year":"2016","journal-title":"J Med Chem"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/jop.2020.0137","article-title":"Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates","volume":"37","author":"Roy Chowdhury","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"e0179345","DOI":"10.1371\/journal.pone.0179345","article-title":"ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1\/2 signaling pathway","volume":"12","author":"Roy Chowdhury","year":"2017","journal-title":"PLoS One"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fmicb.2018.00415","article-title":"Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection","volume":"9","author":"Kers","year":"2018","journal-title":"Front Microbiol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1167\/iovs.11-7523","article-title":"ATP-sensitive potassium (KATP) channel activation decreases intraocular pressure in the anterior chamber of the eye","volume":"52","author":"Chowdhury","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/jop.2016.0188","article-title":"The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies","volume":"34","author":"Cavet","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1167\/iovs.11-9120","article-title":"Human aqueous humor phosphatase activity in cataract and glaucoma","volume":"53","author":"Latarya","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/BF00414848","article-title":"A study on alkaline phosphatase in cornea of various animals with special regard to keratocytes","volume":"204","author":"Cejkova","year":"1977","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"}],"container-title":["Investigative Opthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:34Z","timestamp":1791927094000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2778787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.63.4.26","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}